Physician profile
Ryan Khalil
NPI 1346827052
$2,599.97
in general payments reported to CMS, 2019-2025
16 companies · $2,231 in 2025
The $2,231 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $369 · 2025: $2,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323 · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,323.35 |
| Education | $276.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $455.74 | 2024-2025 | |
| Abbott Laboratories | $398.45 | 2025 | Ensite, Cardiomems, Mitraclip |
| Novartis Pharmaceuticals Corporation | $383.15 | 2024-2025 | |
| Medtronic, INC. | $348.78 | 2025 | Micra, Symplicity G3, Mycarelink |
| Stryker Corporation | $302.76 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Edwards Lifesciences Corporation | $225.69 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $84.83 | 2025 | Vigilant X4 Crt-D, Accolade Sr, Resonate El Icd Vr |
| Biotronik INC. | $82.34 | 2025 | |
| Abiomed | $67.15 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $55.23 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.62 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $40.67 | 2025 | Farxiga |
| Merck Sharp & Dohme LLC | $35.92 | 2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.33 | 2025 | Jardiance |
| Amgen INC. | $25.98 | 2024 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $20.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.